IDEAYA Biosciences, Inc.
IDYA
$30.24
$0.391.31%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 786.89M | 669.74M | 692.51M | 676.32M | 920.03M |
| Total Receivables | -- | -- | -- | 3.00K | 20.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.76M | 15.86M | 15.36M | 13.39M | 12.17M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 802.66M | 685.60M | 707.87M | 689.71M | 932.21M |
|
|
|||||
| Total Current Assets | 802.66M | 685.60M | 707.87M | 689.71M | 932.21M |
| Net Property, Plant & Equipment | 31.72M | 32.73M | 33.30M | 27.74M | 26.62M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 805.00K | 805.00K | 805.00K | 805.00K | 911.00K |
| Total Assets | 1.19B | 1.04B | 1.10B | 1.12B | 1.24B |
|
|
|||||
| Total Accounts Payable | 18.43M | 17.27M | 17.63M | 15.42M | 12.57M |
| Total Accrued Expenses | 45.26M | 37.75M | 32.91M | 30.35M | 28.09M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 328.00K | 318.00K | 308.00K | 298.00K | -- |
| Total Finance Division Other Current Liabilities | 490.00K | -- | -- | -- | -- |
| Total Other Current Liabilities | 490.00K | -- | -- | -- | -- |
| Total Current Liabilities | 64.51M | 55.34M | 50.85M | 46.07M | 40.66M |
|
|
|||||
| Total Current Liabilities | 64.51M | 55.34M | 50.85M | 46.07M | 40.66M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 26.92M | 26.28M | 25.66M | 18.87M | 18.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.68M | -- | -- | -- | -- |
| Total Liabilities | 93.10M | 81.62M | 76.51M | 64.94M | 59.46M |
|
|
|||||
| Common Stock & APIC | 1.74B | 1.73B | 1.72B | 1.68B | 1.67B |
| Retained Earnings | -653.27M | -772.51M | -695.02M | -622.84M | -492.53M |
| Treasury Stock & Other | 2.05M | 1.52M | 1.59M | 812.00K | 3.84M |
| Total Common Equity | 1.09B | 959.65M | 1.02B | 1.06B | 1.18B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.09B | 959.65M | 1.02B | 1.06B | 1.18B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.09B | 959.65M | 1.02B | 1.06B | 1.18B |
|
|
|||||